LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 377

Search options

  1. Article ; Online: Professor Giuseppe Mancia receives the Excellence Research Award of the Council on Hypertension of the American Heart Association.

    Kreutz, Reinhold

    Blood pressure

    2020  Volume 29, Issue 6, Page(s) 338

    MeSH term(s) American Heart Association ; Awards and Prizes ; Biomedical Research ; History, 20th Century ; History, 21st Century ; Humans ; Hypertension/physiopathology ; Hypertension/therapy ; Italy ; United States
    Language English
    Publishing date 2020-10-28
    Publishing country England
    Document type Biography ; Historical Article ; Journal Article
    ZDB-ID 1170048-8
    ISSN 1651-1999 ; 1651-2480 ; 0803-7051 ; 0803-8023
    ISSN (online) 1651-1999 ; 1651-2480
    ISSN 0803-7051 ; 0803-8023
    DOI 10.1080/08037051.2020.1839221
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Understanding the impact of alcohol on blood pressure and hypertension: From moderate to excessive drinking.

    Algharably, Engi Abdelhady / Meinert, Fabian / Januszewicz, Andrzej / Kreutz, Reinhold

    Kardiologia polska

    2024  Volume 82, Issue 1, Page(s) 10–18

    MeSH term(s) Humans ; Blood Pressure/physiology ; Hypertension/etiology ; Ethanol ; Alcohol Drinking/adverse effects
    Chemical Substances Ethanol (3K9958V90M)
    Language English
    Publishing date 2024-01-17
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 411492-9
    ISSN 1897-4279 ; 0022-9032
    ISSN (online) 1897-4279
    ISSN 0022-9032
    DOI 10.33963/v.kp.98704
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Clinical significance of the rivaroxaban-dronedarone interaction: insights from physiologically based pharmacokinetic modelling.

    Hügl, Burkhard / Horlitz, Marc / Fischer, Kerstin / Kreutz, Reinhold

    European heart journal open

    2023  Volume 3, Issue 1, Page(s) oead004

    Abstract: Patients with atrial fibrillation may require rhythm control therapy in addition to anticoagulation therapy for the prevention of stroke. Since 2012, the European Society of Cardiology and European Heart Rhythm Association guidelines have recommended non- ...

    Abstract Patients with atrial fibrillation may require rhythm control therapy in addition to anticoagulation therapy for the prevention of stroke. Since 2012, the European Society of Cardiology and European Heart Rhythm Association guidelines have recommended non-vitamin K antagonist oral anticoagulants, including rivaroxaban, for the prevention of stroke in patients with atrial fibrillation. During the same period, these guidelines have also recommended dronedarone or amiodarone as second-line rhythm control agents in certain patients with atrial fibrillation and no contraindications. Amiodarone and dronedarone both strongly inhibit
    Language English
    Publishing date 2023-01-23
    Publishing country England
    Document type Journal Article ; Review
    ISSN 2752-4191
    ISSN (online) 2752-4191
    DOI 10.1093/ehjopen/oead004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Diagnosis and management of resistant hypertension.

    Camafort, Miguel / Kreutz, Reinhold / Cho, Myeong-Chan

    Heart (British Cardiac Society)

    2023  

    Abstract: Resistant hypertension is a condition where blood pressure levels remain elevated above target despite changes in lifestyle and concurrent use of at least three antihypertensive agents, including a long-acting calcium channel blocker (CCB), a blocker of ... ...

    Abstract Resistant hypertension is a condition where blood pressure levels remain elevated above target despite changes in lifestyle and concurrent use of at least three antihypertensive agents, including a long-acting calcium channel blocker (CCB), a blocker of the renin-angiotensin system (ACE inhibitor or angiotensin receptor blocker) and a diuretic. To be diagnosed as resistant hypertension, maintaining adherence to therapy is required along with confirmation of blood pressure levels above target by out-of-office blood pressure measurements and exclusion of secondary causes of hypertension. The key management points of this condition include lifestyle changes such as reduced sodium and alcohol intake, regular physical activity, weight loss and discontinuation of substances that can interfere with blood pressure control. It is also recommended that current treatment be rationalised, including single pill combination treatment where antihypertensive drugs should be provided at the maximum tolerated dose. It is further recommended that current drugs be replaced with a more appropriate and less difficult treatment regimen based on the patient's age, ethnicity, comorbidities and risk of drug-drug interactions. The fourth line of treatment for patients with resistant hypertension should include mineralocorticoid receptor antagonists such as spironolactone, as demonstrated in the PATHWAY-2 trial and meta-analyses. Alternatives to spironolactone include amiloride, doxazosin, eplerenone, clonidine and beta-blockers, as well as any other antihypertensive drugs not already in use. New approaches under research are selective non-steroidal mineralocorticoid receptor antagonists such as finerenone, esaxerenone and ocedurenone, selective aldosterone synthase inhibitors such as baxdrostat, and dual endothelin antagonist aprocitentan.
    Language English
    Publishing date 2023-12-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 1303417-0
    ISSN 1468-201X ; 1355-6037
    ISSN (online) 1468-201X
    ISSN 1355-6037
    DOI 10.1136/heartjnl-2022-321730
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Infant Exposure to Antituberculosis Drugs via Breast Milk and Assessment of Potential Adverse Effects in Breastfed Infants: Critical Review of Data.

    Algharably, Engi Abdelhady / Kreutz, Reinhold / Gundert-Remy, Ursula

    Pharmaceutics

    2023  Volume 15, Issue 4

    Abstract: Infants of mothers treated for tuberculosis might be exposed to drugs via breast milk. The existing information on the exposure of breastfed infants lacks a critical review of the published data. We aimed to evaluate the quality of the existing data on ... ...

    Abstract Infants of mothers treated for tuberculosis might be exposed to drugs via breast milk. The existing information on the exposure of breastfed infants lacks a critical review of the published data. We aimed to evaluate the quality of the existing data on antituberculosis (anti-TB) drug concentrations in the plasma and milk as a methodologically sound basis for the potential risk of breastfeeding under therapy. We performed a systematic search in PubMed for bedaquiline, clofazimine, cycloserine/terizidone, levofloxacin, linezolid, pretomanid/pa824, pyrazinamide, streptomycin, ethambutol, rifampicin and isoniazid, supplemented with update references found in LactMed
    Language English
    Publishing date 2023-04-13
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527217-2
    ISSN 1999-4923
    ISSN 1999-4923
    DOI 10.3390/pharmaceutics15041228
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Sex and gender in hypertension guidelines.

    Meinert, Fabian / Thomopoulos, Costas / Kreutz, Reinhold

    Journal of human hypertension

    2023  Volume 37, Issue 8, Page(s) 654–661

    Abstract: This paper reviews 11 current and previous international and some selected national hypertension guidelines regarding sex and gender-related differences. Those differences can be attributed to biological sex and to gender differences that are determined ... ...

    Abstract This paper reviews 11 current and previous international and some selected national hypertension guidelines regarding sex and gender-related differences. Those differences can be attributed to biological sex and to gender differences that are determined by socially constructed norms. All reviewed guidelines agree on a higher hypertension prevalence in men than in women. They also concur that evidence does not support different blood pressure thresholds and targets for treatment between men and women. Differences refer in addition to the differences in epidemiological aspects to differences in some morphometric diagnostic indices, e.g., left ventricular mass or the limits for daily alcohol intake. Concerning practical management, there are hardly any clear statements on different procedures that go beyond the consensus that blockers of the renin-angiotensin system should not be used in women of childbearing age wishing to become pregnant. Some further sex-specific aspects are related to differences in tolerability or drug-specific side effects of BP-lowering drugs. There is also a consensus about the need for blood pressure monitoring before and during the use of contraceptive pills. For management of pregnancy, several guidelines still recommend no active treatment in pregnant women without severe forms of hypertension, despite a wide consensus about the definition of hypertension in pregnancy. A disparity in treatment targets when treating severe and non-severe hypertension in pregnancy is also observed. Overall, sex-specific aspects are only very sparsely considered or documented in the evaluated guidelines highlighting an unmet need for future clinical research on this topic.
    MeSH term(s) Humans ; Male ; Female ; Hypertension/diagnosis ; Hypertension/drug therapy ; Hypertension/epidemiology ; Antihypertensive Agents/therapeutic use ; Guidelines as Topic ; Sex Factors ; Blood Pressure
    Chemical Substances Antihypertensive Agents
    Language English
    Publishing date 2023-01-10
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 639472-3
    ISSN 1476-5527 ; 0950-9240
    ISSN (online) 1476-5527
    ISSN 0950-9240
    DOI 10.1038/s41371-022-00793-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Response to letter to the editor "Should women have lower thresholds for hypertension diagnosis and treatment".

    Meinert, Fabian / Thomopoulos, Costas / Kreutz, Reinhold

    Journal of human hypertension

    2023  Volume 37, Issue 8, Page(s) 755

    Language English
    Publishing date 2023-05-12
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 639472-3
    ISSN 1476-5527 ; 0950-9240
    ISSN (online) 1476-5527
    ISSN 0950-9240
    DOI 10.1038/s41371-023-00839-5
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: A new cell line based coculture system for skin sensitisation testing in one single assay using T cells, aryl hydrocarbon receptor knockout, and co-inhibitory blockage.

    Sonnenburg, Anna / Stahlmann, Ralf / Kreutz, Reinhold / Peiser, Matthias

    Archives of toxicology

    2023  Volume 97, Issue 6, Page(s) 1677–1689

    Abstract: Established in vitro assays for regulatory testing of skin sensitisation partly suffer from only moderate sensitivity, specificity, and predictivity when testing specific groups of chemicals. This may be due to limited biomarker response in vitro in cell ...

    Abstract Established in vitro assays for regulatory testing of skin sensitisation partly suffer from only moderate sensitivity, specificity, and predictivity when testing specific groups of chemicals. This may be due to limited biomarker response in vitro in cell types that interact as crucial players of in vivo skin sensitisation pathogenesis. Here, we propose a molecular approach to overcome this limitation. In our model, we apply genome editing and blocking of immunoregulatory molecules to increase the range of biomarker modulation by sensitising chemicals. To this end, aryl hydrocarbon receptor (AhR) knockout was done by CRISPR/Cas9 technology in THP-1 cells and combined with Programmed Cell Death-Ligand (PD-L)1 blockade. AhR-knockout THP-1 in coculture with HaCaT keratinocytes showed increased CD54 expression compared to wild type cells after stimulation with 10 µmol/L dinitrochlorobenzene (DNCB) that was further enhanced by anti-PD-L1. After stimulation of AhR-knockout THP-1 with 200 µmol/L mercaptobenzothiazol or 10 µmol/L DNCB, cocultivated Jurkat T cells significantly increased expression of T cell receptor-associated CD3. No such increase was detected after prior treatment of THP-1 with 150 µmol/L of irritant sodium lauryl sulphate. Additionally, higher levels of inflammatory cytokines MIP-3α, MIP-1β, TNF-α, and IL-8 were found in supernatants of enhanced loose-fit co-culture based sensitisation assay (eLCSA) after substance treatment. Hence, eLCSA allowed to discriminate between sensitisers and non-sensitisers. Thus, inhibition of immunoinhibitory pathway signalling by combining AhR knockout and PD-L1 antibody blockage into an assay involving main acting cell types in skin sensitisation may increase sensitivity and specificity of such assays and allow potency derivation.
    MeSH term(s) Biomarkers/metabolism ; Cell Line ; Coculture Techniques ; Dinitrochlorobenzene ; Receptors, Aryl Hydrocarbon/genetics ; THP-1 Cells ; Humans ; Jurkat Cells ; Skin Tests
    Chemical Substances Biomarkers ; Dinitrochlorobenzene ; Receptors, Aryl Hydrocarbon
    Language English
    Publishing date 2023-05-05
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 124992-7
    ISSN 1432-0738 ; 0340-5761
    ISSN (online) 1432-0738
    ISSN 0340-5761
    DOI 10.1007/s00204-023-03506-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: The 2023 European Society of Hypertension guidelines for high blood pressure - What's new on diagnostic and therapeutic approaches.

    Grassi, Guido / Kreutz, Reinhold / Mancia, Giuseppe

    Pharmacological research

    2023  Volume 199, Page(s) 107003

    MeSH term(s) Humans ; Hypertension/diagnosis ; Hypertension/drug therapy ; Antihypertensive Agents/therapeutic use ; Blood Pressure
    Chemical Substances Antihypertensive Agents
    Language English
    Publishing date 2023-11-18
    Publishing country Netherlands
    Document type Editorial
    ZDB-ID 1003347-6
    ISSN 1096-1186 ; 0031-6989 ; 1043-6618
    ISSN (online) 1096-1186
    ISSN 0031-6989 ; 1043-6618
    DOI 10.1016/j.phrs.2023.107003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Orthostatic hypotension an important phenotype in the 2023 European Society of Hypertension guidelines: how to measure it?

    Kreutz, Reinhold / Palatini, Paolo / Stergiou, George / Mancia, Giuseppe

    Journal of hypertension

    2023  Volume 42, Issue 1, Page(s) 188–189

    MeSH term(s) Humans ; Hypotension, Orthostatic/diagnosis ; Hypertension/diagnosis ; Blood Pressure
    Language English
    Publishing date 2023-11-30
    Publishing country Netherlands
    Document type Letter ; Comment
    ZDB-ID 605532-1
    ISSN 1473-5598 ; 0263-6352 ; 0952-1178
    ISSN (online) 1473-5598
    ISSN 0263-6352 ; 0952-1178
    DOI 10.1097/HJH.0000000000003618
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top